Alongside its earnings results, Manulife (MFC) announced the ~$1.2B acquisition of a 75% stake in Comvest - a U.S. private credit platform with ~$20B of AUM. Compared to MFC’s ~$1T under management, the transaction is small…

… but meaningful in the context of private credit, where MFC only has $5B today. Management likes the category, highlighting expected market runway…

❝

… this is a market that’s expected to double in the next 4 to 5 years in terms of potential opportunity. And if you just look at the track record of Comvest, they’ve grown their fee earning AUM by a CAGR of 50% since 2020.

Paul Lorentz (CEO of GWAM) - MFC Q2’25 call

… and distribution synergies across MFC’s global footprint as factors supporting the continued growth of the strategy.

The market seems unconvinced for now, sending the stock down 4% - as sub-1% EPS accretion from the deal likely has investors wondering: why doesn’t Manulife just buy back stock (~2% accretion)?

My take: this is a more defensive acquisition than management is letting on. Private credit is hot and Manulife is late to the party. If clients have to get that exposure elsewhere…

❝

… private credit is a fast-growing and in high demand strategy from our clients.

Philip Witherington (CEO) - MFC Q2’25 call

… the door opens for the new manager to pull additional capital away from Manulife. The deal rationale isn’t near-term accretion, it’s avoiding the longer-term dilution that comes from not meeting client needs.

You might be interested in…

About Bullpen: Bullpen Finance Inc. publishes content on Canadian markets and provides paid research coverage of select Canadian issuers. Bullpen is paid in cash by covered issuers, does not accept stock or options, does not hold positions in covered securities, and does not conduct investment banking business. Bullpen and LodeRock Advisors Inc. are affiliated; LodeRock provides investor relations services to issuers, some of whom are covered by Bullpen Research. When a post discusses a covered issuer, a specific disclosure appears at the top of the post. This post is published for general information purposes. It is not personalized investment advice and is not tailored to any individual reader’s circumstances. Bullpen is not a registered investment adviser or dealer. For full disclosures, including analyst certification, jurisdictional statements, and conflict of interest policies, please see our Legal & Disclosures section on our website.